{"id":57313,"date":"2024-07-17T00:04:56","date_gmt":"2024-07-17T00:04:56","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/07\/17\/amendment-of-disclosures-in-past-management-information-circulars\/"},"modified":"2024-07-17T00:04:56","modified_gmt":"2024-07-17T00:04:56","slug":"amendment-of-disclosures-in-past-management-information-circulars","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/","title":{"rendered":"Amendment of Disclosures in Past Management Information Circulars"},"content":{"rendered":"<div>\n<p align=\"justify\">VANCOUVER, British Columbia, July  16, 2024  (GLOBE NEWSWIRE) &#8212; As a result of a review by the British Columbia Securities Commission, BetterLife Pharma Inc. (\u201cBetterLife\u201d or the \u201cCompany\u201d) (CSE: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pvkcJkvvtpynv9wu8j0ZVeV5fBPK3L0voY2mW9JAMeEfacbVS7PB_18STvUMOcu7znklduQKexKWoawI8WH2SRezVUfrzMSxlrXv6CKIdIb919_4gZDFMIaN9Ba8bTY7\" rel=\"nofollow noopener\" target=\"_blank\" title=\"BETR\">BETR<\/a> \/\u00a0OTCQB: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Knpg4KGB_ZvotlFKdqE3VVqEiZ7Izfw2zv6Nxc5pMnUegF-_v6O5fGaBiPTcQEjmfW7bF-nUsM_4TWeaNa3Z9MqBykb-WKZinsZR11U2BW0=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"BETRF\">BETRF<\/a> \/ FRA: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=c5DB9103egOEZr4RJB67HIK7ENijMcYuYSNHXiJX9nc14NORfOdErGTOKX9UfR1ErB7FO5xk2wR1zFLqtouRixctTaMBYEWmwy8Bx5gWGNC8n8iGUi6YLSOTHKeBZfuc\" rel=\"nofollow noopener\" target=\"_blank\" title=\"NPAU\">NPAU<\/a>), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid diethylamide (\u201cLSD\u201d), is issuing the following press release to clarify disclosures in its past Management Information Circulars (\u201cMIC\u201d) as it relates to beneficial ownership by its Chief Executive Officer, Dr. Ahmad Doroudian:<\/p>\n<table style=\"border-collapse: collapse; width:100%; border-collapse:collapse ;\">\n<tr>\n<td style=\"max-width:25%; width:25%; min-width:25%;;border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Dates of MIC and <br \/>Related Record <br \/>Dates<\/p>\n<p><\/strong><\/td>\n<td style=\"max-width:25%; width:25%; min-width:25%;;border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Section in MIC<\/p>\n<p><\/strong><\/td>\n<td style=\"max-width:25%; width:25%; min-width:25%;;border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Amount of Beneficial <br \/>Ownership and <br \/>Percentage of Class (if <br \/>applicable) as <br \/>Disclosed in MIC<br \/><\/strong><\/td>\n<td style=\"max-width:25%; width:25%; min-width:25%;;border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: bottom ; \"><strong>Amended Amount of <br \/>Beneficial Ownership <br \/>and Percentage of <br \/>Class (if applicable)<\/p>\n<p><\/strong><\/td>\n<\/tr>\n<tr>\n<td style=\"border-top: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">February 28 and <br \/>February 10, 2023<\/p>\n<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">Proposal No. 2 \u2013 Election of <br \/>Directors<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">5,506,367 common<\/td>\n<td style=\"border-top: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">5,863,786 common<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">November 23 and <br \/>November 5, 2021<\/p>\n<\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">Proposal No. 2 \u2013 Election of <br \/>Directors<\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">5,155,162 common<\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">5,529,887 common<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">November 20 and <br \/>November 9, 2020<\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">Voting Securities and <br \/>Principal Holders of Voting <br \/>Securities<\/p>\n<\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">5,155,162 common<br \/>13.9%<\/td>\n<td style=\"text-align: center ;  vertical-align: middle; vertical-align: top ; \">5,251,637 common<br \/>14.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">February 15 and <br \/>February 13, 2019<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">Principal Stockholders and <br \/>Security Ownership of <br \/>Management<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">9,161,929 common<br \/>9.455%<\/td>\n<td style=\"border-bottom: solid black 1pt ; text-align: center ;  vertical-align: middle; vertical-align: top ; \">21,330,518 common<br \/>22.01%<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">The Company also announces that it has issued 350,000 common shares and 350,000 share purchase warrants pursuant to the conversion of convertible debentures totalling $35,000. Share purchase warrants are exercisable into common shares, on a one-for-one basis, at an exercise price of $0.10 per warrant and expires on August 31, 2026.<\/p>\n<p align=\"justify\"><strong>About BetterLife Pharma <\/strong><\/p>\n<p align=\"justify\">BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.<\/p>\n<p align=\"justify\">BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non- controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife\u2019s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders.<\/p>\n<p align=\"justify\">BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife\u2019s pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency.<\/p>\n<p align=\"justify\">BetterLife also owns a drug candidate for the treatment of viral infections and is in the process of seeking strategic alternatives for further development.<\/p>\n<p align=\"justify\">For further information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=iSWCa4WG0Ra3R6lkRUbu8UGgZWkDuok3OUdmjsSMWA3G4vqY6vALS_TBMUw_JClKjSzj3ES1QOp51qqPrGk0EtvzboT7iNg6FHXQsNzkkyubaDu-RGgKCHCOHkS64N6CEkUduA6O9CFNK0yBkWQvFzWTIqLNyf3CrLPKFqAP0h7LmKZEDO9vICDBuwEJq76gOA_yguDcqoB971gbEUnWRiJEJF1Bd7LVWtMyppipzW9tHfVyRXqiA7bUsJMsjLEm\" rel=\"nofollow noopener\" target=\"_blank\" title=\"BetterLife Pharma\">BetterLife Pharma<\/a>.<\/p>\n<p align=\"justify\"><strong>Contact<\/strong><\/p>\n<p align=\"justify\">David Melles, Investor Relations Manager <br \/>Email: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NkXWYoqvSeWa-VyFxrhoiRW701ex4ud5KKMekUEMJdmONSg9vFiyxJXusiUV_zyv8uvg2as_ZI3TEorLl82Fty_Us4-kDrOpf0gwK9pLOUCFH4C4Q7mZ2l14wx6TolYq\" rel=\"nofollow noopener\" target=\"_blank\" title=\"David.Melles@blifepharma.com\">David.Melles@blifepharma.com<\/a><br \/>Phone: 1-778-887-1928<\/p>\n<p align=\"justify\"><strong>Cautionary Note Regarding Forward-Looking Statements<\/strong><\/p>\n<p align=\"justify\">No securities exchange has reviewed nor accepts responsibility for the adequacy or accuracy of the content of this news release. This news release contains forward-looking statements relating to product development, licensing, commercialization and regulatory compliance issues and other statements that are not historical facts. Forward-looking statements are often identified by terms such as \u201cwill\u201d, \u201cmay\u201d, \u201cshould\u201d, \u201canticipate\u201d, \u201cexpects\u201d and similar expressions. All statements other than statements of historical fact, included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company\u2019s expectations include the failure to satisfy the conditions of the relevant securities exchange(s) and other risks detailed from time to time in the filings made by the Company with securities regulations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable law.<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDZjOGZhODktYmRiZi00MDkxLTkwZWQtYTRiZDc3Yjg5Y2I2LTEyMTY1MjQ=\/tiny\/BetterLife-Pharma-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) &#8212; As a result of a review by the British Columbia Securities Commission, BetterLife Pharma Inc. (\u201cBetterLife\u201d or the \u201cCompany\u201d) (CSE: BETR \/\u00a0OTCQB: BETRF \/ FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic derivative of lysergic acid diethylamide (\u201cLSD\u201d), is issuing [&#8230;]\n","protected":false},"author":1,"featured_media":57314,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-57313","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Amendment of Disclosures in Past Management Information Circulars - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amendment of Disclosures in Past Management Information Circulars\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) &#8212; As a result of a review by the British Columbia Securities Commission, BetterLife\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-07-17T00:04:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/07\/BetterLife-Pharma-Inc-1-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Amendment of Disclosures in Past Management Information Circulars\",\"datePublished\":\"2024-07-17T00:04:56+00:00\",\"dateModified\":\"2024-07-17T00:04:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\"},\"wordCount\":698,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\",\"name\":\"Amendment of Disclosures in Past Management Information Circulars - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-07-17T00:04:56+00:00\",\"dateModified\":\"2024-07-17T00:04:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amendment of Disclosures in Past Management Information Circulars\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amendment of Disclosures in Past Management Information Circulars - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/","og_locale":"en_US","og_type":"article","og_title":"Amendment of Disclosures in Past Management Information Circulars","og_description":"VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) &#8212; As a result of a review by the British Columbia Securities Commission, BetterLife","og_url":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-07-17T00:04:56+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/07\/BetterLife-Pharma-Inc-1-1.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Amendment of Disclosures in Past Management Information Circulars","datePublished":"2024-07-17T00:04:56+00:00","dateModified":"2024-07-17T00:04:56+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/"},"wordCount":698,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/","url":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/","name":"Amendment of Disclosures in Past Management Information Circulars - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-07-17T00:04:56+00:00","dateModified":"2024-07-17T00:04:56+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/amendment-of-disclosures-in-past-management-information-circulars\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Amendment of Disclosures in Past Management Information Circulars"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/57313","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=57313"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/57313\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/57314"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=57313"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=57313"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=57313"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}